TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
Launched by UNIVERSITY OF TASMANIA · Jan 14, 2022
Trial Information
Current as of October 25, 2025
Recruiting
Keywords
ClinConnect Summary
The TAS Test study is looking to develop a new online test that can help identify early signs of Alzheimer's disease before any noticeable symptoms appear. Alzheimer's is a serious condition that affects memory and cognitive abilities, and it's important to catch it early so that treatments can be more effective. This trial combines hand movement tests with advanced computer technology so that people can take the test from the comfort of their own homes. The researchers will analyze how people's hands move and use that information, along with other cognitive performance data, to predict the risk of developing Alzheimer's in the next five years.
To participate in this study, you need to be over 50 years old and not already diagnosed with dementia. If you join, you can expect to take some simple hand movement tests online, and your data will help researchers better understand how to detect Alzheimer's early. This is an exciting opportunity to contribute to important research that could lead to better early detection methods for Alzheimer's disease.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: \> 50years old
- • Exclusion Criteria: established diagnosis of dementia
About University Of Tasmania
The University of Tasmania is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses its expertise in various fields, including medicine, health sciences, and public health, to conduct rigorous and ethically sound research. Committed to fostering a culture of excellence, the University of Tasmania aims to translate research findings into practical applications that benefit the community and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hobart, Tasmania, Australia
Patients applied
Trial Officials
Prof Vickers, PhD DSc
Study Director
University of Tasmania
A/Prof Bai, PhD MSc
Principal Investigator
University of Tasmania
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials